Safety of AS04‐HPV‐16/18 vaccine in Chinese women aged 26 years and older and long‐term protective effect in women vaccinated at age 18–25 years: A 10‐year follow‐up study-Reference-Cited by-同舟云学术

Safety of AS04‐HPV‐16/18 vaccine in Chinese women aged 26 years and older and long‐term protective effect in women vaccinated at age 18–25 years: A 10‐year follow‐up study

Published:2022-09-13 Issue: Volume: Page:
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clncl Oncology

Author:

Zhao Fanghui¹,Jastorff Archana²,Hong Ying³,Hu Shangying¹,Chen Wen¹,Xu Xiaoqian¹,Zhu Yejiang⁴,Zhu Jiahong⁵,Zhang Xun¹,Zhang Wenhua¹,Xu Dacheng⁶,Wang Dali⁴,Tang Rong⁷,Sun Yonghong⁸,Shen Yiping⁶,Pan Qinjing¹,Yin Jian¹,Liu Daokuan¹,Liu Bin¹,Karkada Naveen⁹,Jiang Chunmei⁸,Cui Jianfeng¹,Chen Feng¹,Bi Jun⁸,Bao Yuqing⁵,Zhou Xin⁶,Cartier Cyrille⁹,Hu Yuemei⁷^ORCID,Borys Dorota⁹

Affiliation:

1. National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

2. Modis Life Sciences c/o GSK Wavre Belgium

3. Drum Tower Hospital of Nanjing University Medical School Nanjing China

4. Binhai Center for Disease Control and Prevention Binhai China

5. Lianshui Center for Disease Control and Prevention Changzhou China

6. Jintan Center for Disease Control and Prevention Huaian China

7. Jiangsu Provincial Center for Disease Control and Prevention Nanjing China

8. Xuzhou City Center for Disease Control and Prevention Xuzhou China

9. GSK Wavre Belgium

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13833

Reference31 articles.

1. BruniL AlberoG SerranoB et al.ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report. 17 June2019. [Accessed 29 January 2021].

2. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis

3. BruniL AlberoG SerranoB et al.ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in China. Summary Report. 17 June2019. [Accessed 17 August 2020].

4. The natural history of human papillomavirus infection

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the seroprevalence of human papillomavirus in Guangdong, China: Implications for vaccination strategies;Journal of Medical Virology;2024-09

2. Metal-based approaches to fight cervical cancer;Drug Discovery Today;2024-08

3. Opportunities and challenges for human papillomavirus vaccination in China;Human Vaccines & Immunotherapeutics;2024-04-04

4. Formulations and mechanisms of action of novel vaccine adjuvants;Metabolomics for Personalized Vaccinology;2024

5. Efficacy, immunogenicity and safety of HPV vaccination in Chinese population: A meta-analysis;Frontiers in Public Health;2023-02-17